{
    "Trade/Device Name(s)": [
        "ADVIA Chemistry Total Bilirubin 2",
        "ADVIA Chemistry Total Bilirubin_2"
    ],
    "Submitter Information": "Siemens Medical Solutions Diagnostics (formerly Bayer HealthCare, LLC, Diagnostics Division)",
    "510(k) Number": "K063845",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992399"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFM"
    ],
    "Summary Letter Date": "December 7, 2007",
    "Summary Letter Received Date": "December 4, 2007",
    "Submission Date": "November 30, 2007",
    "Regulation Number(s)": [
        "21CFR862.1110"
    ],
    "Regulation Name(s)": [
        "Bilirubin (Total or Direct) Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total Bilirubin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Chemistry 1650",
        "ADVIA Chemistry 1800",
        "ADVIA Chemistry 2400",
        "ADVIA Chemistry 1200"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric endpoint",
        "Chemical oxidation (vanadate)"
    ],
    "Methodologies": [
        "Endpoint reaction",
        "Chemical oxidation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Chemistry Total Bilirubin 2 assay using chemical oxidation for quantitative determination of total bilirubin in human serum and plasma.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of total bilirubin in human serum and plasma on the ADVIA Chemistry Systems; measurements aid diagnosis and treatment of hemolytic, biliary, and liver disorders including hepatitis and cirrhosis.",
    "fda_folder": "Clinical Chemistry"
}